TY - JOUR
T1 - Wastewater-based epidemiology for the assessment of population exposure to chemicals
T2 - The need for integration with human biomonitoring for global One Health actions
AU - Kasprzyk-Hordern, Barbara
AU - Béen, Frederic
AU - Bijlsma, Lubertus
AU - Brack, Werner
AU - Castiglioni, Sara
AU - Covaci, Adrian
AU - Martincigh, Bice S
AU - Mueller, Jochen F
AU - van Nuijs, Alexander L N
AU - Oluseyi, Temilola
AU - Thomas, Kevin V
N1 - Funding Information:
The authors would like to acknowledge support from the EU Interwaste Project ‘Synergising International Research Studies into the Environmental Fate and Behaviour of Toxic Organic Chemicals in the Waste Stream’ (Grant agreement ID: 734522). L. Bijlsma acknowledges that the project that gave rise to these results received the support of a fellowship from “la Caixa” Foundation (ID 10 0 010434). The fellowship code is LCF/BQ/PR21/11840012. He also acknowledges grant RYC2020-028936-I funded by MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in Your Future”. Support from Engineering and Physical Sciences Research Council (EP/V028499/1) is also appreciated.
Data availability
No data was used for the research described in the artic
PY - 2023/5/15
Y1 - 2023/5/15
N2 - WBE has now become a complimentary tool in SARS-CoV-2 surveillance. This was preceded by the established application of WBE to assess the consumption of illicit drugs in communities. It is now timely to build on this and take the opportunity to expand WBE to enable comprehensive assessment of community exposure to chemical stressors and their mixtures. The goal of WBE is to quantify community exposure, discover exposure-outcome associations, and trigger policy, technological or societal intervention strategies with the overarching aim of exposure prevention and public health promotion. To achieve WBE's full potential, the following key aspects require further action: (1) Integration of WBE-HBM (human biomonitoring) initiatives that provide comprehensive community-individual multichemical exposure assessment. (2) Global WBE monitoring campaigns to provide much needed data on exposure in low- and middle-income countries (LMICs) and fill in the gaps in knowledge especially in the underrepresented highly urbanised as well as rural settings in LMICs. (3) Combining WBE with One Health actions to enable effective interventions. (4) Advancements in new analytical tools and methodologies for WBE progression to enable biomarker selection for exposure studies, and to provide sensitive and selective multiresidue analysis for trace multi-biomarker quantification in a complex wastewater matrix. Most of all, further developments of WBE needs to be undertaken by co-design with key stakeholder groups: government organisations, health authorities and private sector.
AB - WBE has now become a complimentary tool in SARS-CoV-2 surveillance. This was preceded by the established application of WBE to assess the consumption of illicit drugs in communities. It is now timely to build on this and take the opportunity to expand WBE to enable comprehensive assessment of community exposure to chemical stressors and their mixtures. The goal of WBE is to quantify community exposure, discover exposure-outcome associations, and trigger policy, technological or societal intervention strategies with the overarching aim of exposure prevention and public health promotion. To achieve WBE's full potential, the following key aspects require further action: (1) Integration of WBE-HBM (human biomonitoring) initiatives that provide comprehensive community-individual multichemical exposure assessment. (2) Global WBE monitoring campaigns to provide much needed data on exposure in low- and middle-income countries (LMICs) and fill in the gaps in knowledge especially in the underrepresented highly urbanised as well as rural settings in LMICs. (3) Combining WBE with One Health actions to enable effective interventions. (4) Advancements in new analytical tools and methodologies for WBE progression to enable biomarker selection for exposure studies, and to provide sensitive and selective multiresidue analysis for trace multi-biomarker quantification in a complex wastewater matrix. Most of all, further developments of WBE needs to be undertaken by co-design with key stakeholder groups: government organisations, health authorities and private sector.
KW - Human Biomonitoring (HBM)
KW - Human chemical exposure
KW - Mass spectrometry
KW - One Health
KW - Wastewater-Based Epidemiology (WBE)
UR - http://www.scopus.com/inward/record.url?scp=85149236077&partnerID=8YFLogxK
U2 - 10.1016/j.jhazmat.2023.131009
DO - 10.1016/j.jhazmat.2023.131009
M3 - Article
C2 - 36863100
SN - 0304-3894
VL - 450
JO - Journal of Hazardous Materials
JF - Journal of Hazardous Materials
M1 - 131009
ER -